Cancer ameliorating potential of Phyllanthus amarus: In vivo and in vitro studies against Aflatoxin B1 toxicity  by Ahmad, Md. Sultan et al.
The Egyptian Journal of Medical Human Genetics (2015) 16, 343–353HO ST E D  BY
Ain Shams University
The Egyptian Journal of Medical Human Genetics
www.ejmhg.eg.net
www.sciencedirect.comORIGINAL ARTICLECancer ameliorating potential of Phyllanthus
amarus: In vivo and in vitro studies against
Aﬂatoxin B1 toxicityAbbreviations: CA, chromosomal aberration; SCE, sister chromatid
exchange; RI, replication index; AFB1, Aﬂatoxin B1; S9 mix, liver
microsomal metabolic activation system
* Corresponding author. Mobile: +91 9335753122.
E-mail address: sultansnc@gmail.com (M.S. Ahmad).
Peer review under responsibility of Ain Shams University.
http://dx.doi.org/10.1016/j.ejmhg.2015.05.005
1110-8630  2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Ain Shams University.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Md. Sultan Ahmad *, Sultana Bano, Shafaat AnwarDepartment of Zoology, Shibli National (P.G) College, Azamgarh, U.P. 276001, IndiaReceived 17 April 2015; accepted 14 May 2015
Available online 10 June 2015KEYWORDS
Antigenotoxicity;
Phyllanthus amarus;
Chromosomal aberration;
Sister chromatid exchange;
Green medicineAbstract Background: Green medicine is safe and more dependable than the costly synthetic
drugs. Phyllanthus amarus is one of them that have enormous medicinal potential.
Aim: In these experiments, we have evaluated the anticlastogenic, antigenotoxic and antimuta-
genic potential of P. amarus extract.
Subject and methods: In this experiment we have used in vitro human lymphocyte culture and
in vivo bone marrow cells of Albino mice. The parameters used were chromosomal aberrations
(CA), sister chromatid exchanges (SCEs) and cell growth kinetics (RI) both in the presence as well
as in the absence of S9-mix (for in vitro study) and total aberrant cells and the frequencies of aber-
rations per cell (for in vivo study). Alcoholic extracts of P. amarus was obtained by Soxhlet extrac-
tor.
Results: Extracts of P. amarus signiﬁcantly reduces chromosomal aberrations from 34.49%,
68.47% and 78.65% at 24 h, 48 h, and 72 h produced by Aﬂatoxin B1 (AFB1) to 19.32%,
48.00% and 51.88% level. Similarly sister chromatid exchanges were reduced from 17.76 ± 1.50
(SE) to 09.76 ± 1.20 (SE) at 48 h of treatment, whereas replication index was enhanced in vitro
for each concentration and duration of treatment. It also signiﬁcantly reduced the number of aber-
rant cells and frequency of aberrations per cell in vivo.
Conclusion: Ameliorating potential of P. amarus was dose and duration dependant. These
extracts signiﬁcantly reduced the mutagenicity and genotoxicity that were produced due to AFB1
treatment both in vitro and in vivo.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Ain Shams University. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Bioactive components used as medicine are cheaper and safer
than the costly synthetic drugs. Screening of compounds
obtained from plants for their pharmacological activity has
resulted in the isolation of innumerable therapeutic agents.
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antigenotoxic and antimutagenic i.e., anticancerous potential
of Phyllanthus extract. Phyllanthus amarus is widely distributed
in all tropical regions of the planet. It is a member of the
Euphorbiaceae family, which contains 6500 species in 300 gen-
era. In folk medicine, extracts of P. amarus have reportedly
been used to treat jaundice, diabetes, swelling, skin ulcer, gas-
trointestinal disturbances and blocks DNA polymerase in the
case of hepatitis B virus during reproduction [1]. The plant is
bitter, astringent, diuretic, stomachic and antiseptic. Its anti-
fungal, antiviral and anticancerous properties have also been
demonstrated in experimental animals [2].
Several compounds including alkaloids, ﬂavonoids, lignans,
phenols and terpenes were isolated from this plant and some of
them interact with most key enzymes. In traditional medicine,
it is used for its hepatoprotective, antihypertensive, analgesic
and anti-inﬂammatory properties [3].
Phyllanthenol, phyllanthenone and phyllantheol are the
three triterpenes and two lignins i.e., nirphyllin and phyll-
nirurin were isolated from aerial parts of plant [4] The
methanolic extract of P. amarus was found to inhibit lipid per-
oxidation, and scavenge hydroxyl and superoxide radicals in
diabetic models and thus showed potent antidiabetic activity
[5]. P. amarus treatment increased the activity of antioxidant
enzymes, like superoxide dismutase (SOD), catalase (CAT),
glutathione-S-transferase (GST), glutathione peroxidase
(GPX) and glutathione reductase (GR) both in blood and tis-
sue showing the antioxidant potential of the plant [6].
The methanolic extract of P. amarus leaves (50–800 mg/kg)
caused a decrease in the levels of total cholesterol, urea, and
total protein, prostatic, alkaline and acid phosphatases.
These effects were dose and time-dependent. This shows that
the leaves of P. amarus have hepato-protective, nephro-
protective and cardio protective properties [7].
2. Materials and methods
2.1. Materials
The whole plant was powdered in a mixture-grinder and the
hydro-alcoholic extract was prepared by reﬂuxing with the
double distilled water (DDW) and alcohol (3:1) in a round bot-
tom ﬂask for 36 h at 60 C. The liquid extract was ﬁltered,
cooled and concentrated by evaporating its liquid contents in
oven and collected. The powdered extract, termed
Phyllanthus extract (PA), was re-dissolved in DDW prior to
the administration in mice or used in the culture. The required
doses for treatment were prepared by dissolving the extract in
DDW and we have selected 200, 300, 400, 450 and 500 mg/kg
body weight for in vivo experiments whereas 150, 200, 250 and
300 mg/l for in vitro experiments.
2.2. In vivo method
Albino mice 8–10 weeks old (25–35 g in weight) were exposed
to the above mentioned doses of Phyllanthus extract by intra
peritoneal (IP) injection. The animals were sacriﬁced at
sequential intervals of 16 h, 24 h, and 32 h of stipulated treat-
ment time. The samples were taken separately after each treat-
ment as mentioned above. The central sampling interval was
24 h, since cell cycle kinetics could be inﬂuenced by the testsubstances. The earlier and late sampling intervals were ade-
quately spaced within the range of 6–48 h. The additional dose
levels were tested in subsequent experiments; these samples
were taken at the predetermined duration as earlier published
work [8,9]. The work was carried out following the guideline of
institutional ethics committee and in accordance with The
Code of Ethics of the World Medical Association
(Declaration of Helsinki) for humans and animals.2.2.1. Preparation of slides
Immediately after sacriﬁce, the bone marrow contents were
obtained by standard procedure and exposed to hypotonic
solution and cells were ﬁxed in Carnoy’s ﬁxative.
Chromosome preparations were made from bone marrow cells
following standard procedure as described. The stained slides
were examined and metaphase cells were scored for chromoso-
mal aberrations. Prior to sacriﬁce, mice were further treated
with colchicine, a spindle inhibitor to arrest the cells in C-
metaphase. The slides were stained in 10% aqueous Giemsa
solution and 100 bone marrow metaphase cells from each ani-
mal were scored under code as earlier published work [8,9].
The types of chromosomal aberrations considered were chro-
matid and chromosome gaps, breaks, and fragments,
exchanges and pulverization (severely damaged cells). The
reduction factors due to test chemical treatments were calcu-
lated using the formula:
%Reduction
¼ ðAberrant cells in control aberrant cells in MMS and test chemicalsÞðAberrant cells in control aberrant cells in negative controlÞ2.3. In vitro lymphocyte culture method
Human peripheral blood lymphocytes are extremely sensitive
indicators of the in vitro assay system. The chromosomal
changes (numerical and structural) were utilized for investiga-
tion of the genotoxic as well as antigenotoxic potentiality of
test chemicals. The parameters studied included chromosomal
aberrations (CA), sister chromatid exchanges (SCEs) and cell
growth kinetics (RI) both in the presence and in the absence
of exogenous metabolic activation system [8,9].2.3.1. Preparation of S9 liver/microsome fraction
The S9 liver/microsome fraction formed the exogenous meta-
bolic activation system utilized for the present investigation
and was prepared following the standard procedures as recom-
mended by Maron and Ames [10].
2.3.2. Chromosomal aberrations
2.3.2.1. Preparation of culture media. Tissue culture medium
RPMI-1640 (ﬂow Laboratories) with L-glutamine and Hepes
buffer without NaHCO3 was prepared in advance and stored
at 4 C, but the storage period never lasted longer than a week.
About 1.574 g of medium was dissolved in 100 ml of double
distilled water by gentle shaking. Antibiotics, penicillin
(100 IU/ml) and streptomycin (100 IU/ml) (Hoechst) were also
added and pH was adjusted at 6.8–7.2 with N/10 NaHCO3 and
HCl. The medium was ﬁltered and sterilized using millipore
ﬁltration assembly by 0.45 lm millipore size. The ﬁltered med-
ium was then stored in sterilized tightly capped glass bottles.
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Peripheral blood from the healthy donors was taken fresh
every time through veinal puncture under aseptic conditions
(disposable needle and disposable syringes, Unitech) and
Heparin (500 IU/ml; Micro Lab) was used as anticoagulant.
The tightly capped glass vials were gently mixed and stored
at 4 C for half an hour to separate blood cells from plasma.
Lymphocyte culture was carried out by adding 0.8 ml of
plasma containing white blood cells (WBC) in 4.5 ml of culture
medium supplemented with 0.1 ml phytohaemagglutinin–P
(PHA–P, Micro lab) and 15% fetal calf serum (Gibco). The
culture vials were then tightly capped to avoid CO2 loss and
after gently mixing, culture tubes were incubated at 37 C in
the dark and colchicines were added 2 h prior to harvesting
for arresting the cells at the metaphase stage [8,9].
2.3.2.3. Harvesting of the cultures and slide preparation. After
appropriate durations, the cells were spun down by centrifuga-
tion for 10 min, at 1200 rpm, and pellets saved by discarding
the supernatant. Hypotonic treatment (0.075 M KCl) was car-
ried for 10–12 min at 37 C and the cells were recollected by
centrifugation. The cell pellet was suspended in 5 ml of freshly
prepared chilled ﬁxative (3:1 of methanol and acetic acid),
which was added drop by drop with a pipette while continu-
ously shaking the tube to avoid formation of clots. In order
to ensure the proper ﬁxation, the cells were kept suspended
in the ﬁxative for a minimum period of 1 h though preferably
overnight. Three changes with fresh ﬁxative were given before
preparing the slides. Two or three drops of cell preparation
were dropped over clean, grease free, pre-chilled and wet
microscopic slides and air-dried. One-day-old slides were
stained in Giemsa (Sigma) for 15 min and rinsed in 95% alco-
hol and ﬁnally in the absolute alcohol for proper differentia-
tion. After proper air-drying these slides were dipped in
Xylene for 5 min before mounting in dibutyl phthalate xylene
(DPX).
2.3.2.4. Analysis of the cells. A total of 300 well spread meta-
phases were analyzed for each concentration of the test chem-
icals and for each time duration to analyze various
chromosome and chromatid type aberrations using the method
of Evans [11].
2.3.3. Sister chromatid exchange analysis
Sister chromatid exchange is a sensitive rapid and objective
method of observing reciprocal exchange between sister chro-
matids. This method depends upon the phenomenon of 5-
bromo-2-deoxyuridine (BrdU) incorporation into DNA in
place of thymidine. After two rounds of cell division, the chro-
matids were labeled with BrdU and consequently differentially
stained with Hoechst. The BrdU incorporation quenches the
ﬂuorescence of 33258 Hoechst. Therefore, the light energy is
absorbed but not emitted by such dyes, which results in the
reduced staining of chromatid with Giemsa [12].
2.3.3.1. Labeling of chromosomes with BrdU. The sister chro-
matid exchange analysis was carried out following the stan-
dard procedure of Latt et al [13]. One-day-old slides were
dipped in 0.5 lg/ml of 33,258 Hoechst stain (Sigma) dissolved
in double distilled water in a horizontal coplin jar. The slides
were then put in ﬂat glass dish with the layer of cells facingupwards. These were covered with thick layer (2–3 cm) of
phosphate buffer (pH 6.8) and exposed to UV lamp (15 W,
254 lm, Philips) from a distance of 10–15 cm for 30–45 min.
The slides were taken out from the buffer, washed twice in dou-
ble distilled water and air-dried. These were then incubated in
2X SSC (0.3 M NaCl, 0.03 M sodium citrate, pH 7.0) at 65 C
in water bath for 90 min using vertical coplin jars. The slides
were taken out and rinsed in distilled water. The air-dried slides
were then stained in Giemsa for 20 min and rinsed in 90% alco-
hol followed by rinsing in absolute alcohol. The dried slides were
dipped in Xylene for 5 min and mounted in DPX.
2.3.3.2. Analysis of the cells. Around 50 metaphases (25
metaphases/donor) with differentially stained chromatids were
scored for each dose of treatment in the absence of S9 mix.
Similarly 50 metaphases were also scored in the presence of
S9 mix. Student’s ‘t’ test was applied for calculating the signif-
icance of difference between the treated and the controls.
2.3.4. Cell cycle kinetics analyses
The cells undergoing ﬁrst (M1), second (M2) and third (M3)
divisions were detected by studying the BrdU labeled and dif-
ferentially stained chromosomes, following the method as ear-
lier published [8,9]. The cells with both the chromatids being
darkly stained were scored asM1 cells and those with one dark
and one lightly stained chromatid were taken as M2 cells,
whereas those having a mixture of both the differentially
stained and uniformly stained chromatids were scored as M3
metaphase. Around 200 well spread metaphases were scored
for each concentration and each treatment of duration from
each donor in the absence as well as in the presence of S9
mix. The replication index (RI) was calculated according to
the formula of Tice et al [14] as given below. The deviation
from the controls was determined by using Chi-square (v2)
test.
R:I ¼ ðM1X1Þ þ ðM2X2Þ þ ðM3X3Þ
100
ð1Þ2.4. Statistical Analyses
Chi-square (v2) test for homogeneity test of variance was used
to analyze the cell growth kinetics exchange with the normal
control. The level of signiﬁcance was tested from standard sta-
tistical tables of Fisher and Yates [15].
Student two-tailed ‘t’ test was used for calculating the sta-
tistical signiﬁcance in SCE and chromosomal aberrations by
comparing the effect induced by different doses of extracts
with the respective control. The statistical signiﬁcance was cal-
culated from Fisher and Yates table at (n1 + n2  2) degree of
freedom (df) at 0.05% level of signiﬁcance.3. Results
3.1. In vivo effects
In these in vivo experiments we have selected the ﬁve most opti-
mum concentrations of extract of P. amarus and their effect on
chromosomal aberrations given at three different durations
was calculated and presented in the tables.
Table 1 Effect of Phyllanthus amarus on the frequency of cells with chromosomal aberrations induced by Aﬂatoxin B1
(AFB1 x/kg bw) at 16 h duration.
Treatment PA/kg bw Cell with pulverized
chromosome
Types of chromatic aberrations Aberrant cell No. (%) (%) Reduction
Gaps Breaks Fragments Exchanges
DH2O 00 00 02 07 20 0 27 (2.7)
AFB1 00 15 71 81 99 11 206 (20.6)
PA PA5 00 03 06 19 00 25 (2.5)
AFB1 + PA PA1 08 85 74 86 09 177 (17.7) 14.07
PA2 04 54 63 77 07 151 (15.1) 26.70
*
PA3 02 58 53 64 04 123 (12.3) 40.29
*
PA4 01 61 45 56 02 104 (10.4) 49.51
*
PA5 00 51 38 47 01 86 (8.6) 58.25
*
Note: PA; concentrations of extracts of Phyllanthus amarus, Aﬂatoxin B1 5 lg/ml/kg body weight at 16 h of treatment. Calculations were made
excluding the gaps type of aberration and *signiﬁcant at <0.05 probability. PA/kg bw is the concentration of extracts of Phyllanthus amarus.
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percentage of aberrant cells was 20.6% due to treatment with
Aﬂatoxin B1 (AFB1) which was reduced to 17.7%, 15.1%,
12.3%, 10.4% and 8.6% respectively for ﬁve consecutive con-
centrations of Phyllanthus extract. The fragment types of aber-
rations were most prominent followed by breaks and gaps.
Similarly reduction in the frequencies of clastogenic cells put
the values at 14.07%, 26.70%, 40.29%, 49.51% and 58.25%
against ﬁve different concentrations of Phyllanthus extract
respectively. The trend of effects was linear i.e., as concentra-
tion of Phyllanthus extract increases the effect also increases
(Fig. 1). The gross effect on the total frequencies of aberrations
per thousand cells was 347, 269, 215, 172 and 147 of ﬁve differ-
ent increasing concentrations of Phyllanthus extract against
430 aberrations of AFB1 alone. The normal values were 21
for distilled water treatment (Table 2).
When the treatment duration was increased to 24 h, the
trends of effects were similar, with increasing values. The
observed values were 17.3%, 15.0%, 13.4%, 11.5% and
9.9% due to ﬁve increasing concentrations of PhyllanthusFigure 1 Showing in vivo anticarcinogenic effect of Phyllanthus extr
induced genotoxicity in Albino mice bone marrow cell.extract, against 19.7% of AFB1 alone. The normal values were
2.1% and 2.6% for pure water and Phyllanthus extract alone
respectively. It also shows dose-response relationship
(Table 3). Effect of Phyllanthus extract on the frequency of
aberrations per cell and total decreased in aberrations noticed
were statistically much signiﬁcant. The total aberrations per
thousand cells were 345, 267, 222, 176 and 143 for
Phyllanthus extract against the value of 400 with AFB1 alone
(Table 4).
At 32 h of treatment, we observed 19.8% aberrant cells
for AFB1 alone, and were reduced to 17.1%, 15.5%,
13.3%, 11.9% and 10.4% respectively for ﬁve increasing
concentrations of Phyllanthus extract given with AFB1,
whereas the values for normal control was 2.7%, and the
same for Phyllanthus extract alone were 2.3%. In terms of
the effects on the percent reduction in aberrant cells, the val-
ues were 13.63%, 21.71%, 32.82%, 39.90% and 47.47%
respectively. These values were statistically signiﬁcant at
<0.05 probability level due to Phyllanthus extract on the
number and percentage of aberrant cells. It also showedact at 16 h, 24 h, and 32 h of treatment durations against AFB1
Table 2 Effect of Phyllanthus amarus extract on the frequency of cells with chromosomal aberrations induced by Aﬂatoxin B1 (AFB1
x/kg bw) at 16 h duration.
Treatment PA/kg bw Cell with aberration Total number of aberration
0 1 2 3 4 5 6–9
DH2O 00 973 23 04 00 00 00 00 31
AFB1 00 794 121 29 19 16 12 09 430
PA PA5 975 22 03 00 00 00 00 28
AFB1 + PA PA1 823 113 21 15 12 09 07 347
PA2 849 106 15 11 08 06 05 269
*
PA3 877 81 17 09 10 05 01 215
*
PA4 896 74 11 07 08 03 01 172
*
PA5 914 58 09 08 08 03 00 147
*
Note: PA; concentrations of extracts of Phyllanthus amarus, Aﬂatoxin B1 5 lg/ml/kg body weight at 16 h of treatment. Calculations were made
excluding the gaps type of aberration and *signiﬁcant at <0.05 probability. PA/kg bw is the concentration of Phyllanthus amarus extracts. The
animals were sacriﬁced 16 h after AFB1 treatment. 1000 cells from 10 animals were analyzed for each point.
Table 3 Effect of Phyllanthus amarus on the frequency of cells with chromosomal aberrations induced by Aﬂatoxin B1
(AFB1 x/kg bw) at 24 h duration.
Treatment PA/kg bw Cell with pulverized
chromosome
Types of chromatic aberrations Aberrant cell No. (%) (%) Reduction
Gaps Breaks Fragments Exchanges
DDH2O 00 00 05 04 17 00 21 (2.1)
AFB1 00 11 89 75 101 10 197 (19.7)
PA PA5 00 03 06 20 00 26 (2.6)
AFB1 + PA PA1 09 60 66 90 08 173 (17.3) 12.18
PA2 07 56 57 80 06 150 (15.0) 23.85
*
PA3 04 45 53 72 05 134 (13.4) 31.98
*
PA4 03 41 49 60 03 115 (11.5) 41.62
*
PA5 02 38 39 57 01 99 (9.9) 49.75
*
Note: PA; concentrations of extracts of Phyllanthus amarus, Aﬂatoxin B1 5 lg/ml/kg body weight at 24 h of treatment. Calculations were made
excluding the gap type of aberration and *signiﬁcant at <0.05 probability. PA/kg bw is the concentration of extracts of Phyllanthus amarus.
Table 4 Effect of Phyllanthus amarus extract on the frequency of cells with chromosomal aberrations induced by Aﬂatoxin B1
(AFB1 x/kg bw) at 24 h duration.
Treatment PA/kg bw Cell with aberrations Total number of aberration
0 1 2 3 4 5 6–9
DH2O 00 979 18 03 00 00 00 00 24
AFB1 00 803 119 29 17 13 09 10 400
PA PA5 973 24 03 00 00 00 00 30
AFB1 + PA PA1 827 106 24 15 14 07 07 345
PA2 850 99 20 11 11 06 03 267
*
PA3 866 91 20 09 09 04 01 222
*
PA4 885 81 18 07 07 02 00 176
*
PA5 901 71 15 06 05 02 00 149
*
Note: PA; concentrations of extracts of Phyllanthus amarus, Aﬂatoxin B1 5 lg/ml/kg body weight at 24 h of treatment. Calculations were made
excluding the gaps type of aberration and *signiﬁcant at <0.05 probability. PA/kg bw is the concentration of Phyllanthus amarus extracts. The
animals were sacriﬁced 24 h after AFB1 treatment. 1000 cells from 10 animals were analyzed for each point.
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doses were much effective in comparison with preceding
dose. More of chromosomal exchange types of aberrations
were seen in contrast to the previous two durations oftreatment (Table 5 and Fig. 1). The total frequencies of
aberrations per thousand cells were 416 for AFB1 only
and 325, 282, 228, 203, 167 respectively for Phyllanthus
extract along with AFB1. These values were signiﬁcantly
Table 5 Effect of Phyllanthus amarus on the frequency of cells with chromosomal aberrations induced by Aﬂatoxin B1
(AFB1 x/kg bw) at 32 h duration.
Treatment PA/kg bw Cell with Pulverized
chromosome
Types of chromatic aberrations Aberrant cell No. (%) (%) Reduction
Gaps Breaks Fragments Exchanges
DH2O 00 00 03 04 23 00 27 (2.7)
AFB1 00 14 68 87 85 12 198 (19.8)
PA PA5 00 01 03 20 00 23 (2.3)
AFB1 + PA PA1 11 65 74 77 09 171 (17.1) 13.63
PA2 08 62 69 71 07 155 (15.5) 21.71
*
PA3 05 54 57 70 01 133 (13.3) 32.82
*
PA4 02 49 52 64 01 119 (11.9) 39.90
*
PA5 01 38 42 61 00 104 (10.4) 47.47
*
Note: PA; concentrations of extracts of Phyllanthus amarus, Aﬂatoxin B1 5 lg/ml/kg body weight at 32 h of treatment. Calculations were made
excluding the gaps type of aberration and *signiﬁcant at <0.05 probability. PA/kg bw is the concentration of extracts of Phyllanthus amarus.
Table 6 Effect of Phyllanthus amarus extract on the frequency of cells with chromosomal aberrations induced by Aﬂatoxin B1
(AFB1 x/kg bw) at 32 h duration.
Treatment PA/kg bw Cell with aberration Total number of aberration
0 1 2 3 4 5 6–9
DH2O 00 973 21 06 00 00 00 00 33
AFB1 00 802 115 29 19 14 11 10 416
PA PA5 977 20 03 00 00 00 00 26
AFB1 + PA PA1 829 113 19 14 10 08 07 325
PA2 845 106 17 13 07 06 06 282
*
PA3 867 92 16 11 07 04 03 228
*
PA4 881 82 14 11 05 05 02 203
*
PA5 896 74 12 10 04 03 01 167
*
Note: PA; concentrations of extracts of Phyllanthus amarus, Aﬂatoxin B1 5 lg/ml/kg body weight at 32 h of treatment. Calculations were made
excluding the gap type of aberration and *signiﬁcant at <0.05 probability. PA/kg bw is the concentration of Phyllanthus amarus extracts. The
animals were sacriﬁced 32 h after AFB1 treatment. 1000 cells from 10 animals were analyzed for each point.
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total aberrations as well as aberrations per cell as shown
in Table 6.3.2. In vitro effects
Here the culture treated with Aﬂatoxin B1 (AFB1) resulted in
clastogenic abnormalities as observed in percent metaphase
aberration, types of aberrations and aberration per cell
(34.49%, 68.47% and 78.65% or 0.35, 0.68 and 0.79 aberra-
tions per cell) at single standard dose and three durations
viz., 24 h, 48 h and 72 h respectively whereas, with control,
the normal and DMSO plus Phyllanthus extract, these values
were 0.03, 0.04 per cell. Phyllanthus extract brings down aber-
rations from 34.49% to 28.87%, 24.47%, 21.0% and 19.32%
with four consecutive doses of the extract at 24 h of duration,
whereas at 48 h, it gets lowered from 68.47% to 61.53%,
57.26%, 52.95%, and 48.0% by administration of 1st to 4th
concentrations of Phyllanthus extract respectively. The same
trends were noticed, when the treatment durations were
increased to 72 h. These values showed linear increasing trends
with doses, but it does not depend on durations. The maxi-
mum percentage reductions in the aberrations were 43.98%for 24 h and 29.90% and 34.03% respectively for 48 h and
72 h that were caused by the highest doses of Phyllanthus
extract (Table 7 Fig. 2).
Similarly when the experiment was setup along with meta-
bolic activation system (+S9 mix) the effect of AFB1 got
increased. The effect of Phyllanthus extract also showed a sim-
ilar trend; they lower the clastogenic activity of AFB1. These
values were linearly increased with doses (Table 8, Fig. 3).
The maximum effective percentage reductions were 40.40%,
32.00%, and 35.30% for 24 h, 48 h and 72 h respectively.
When sister chromatid exchanges were counted (Table 9 and
10) the reduction was evident both in the absence as well as
in the presence of metabolic activation; there being a lowering
of the mean range and the total SCEs and SCE per cell
from 15.92 to 08.38 and from 17.76 to 09.76. For the analysis
of SCE, only 48 h cultures were used and 50 metaphases
were scanned. The effects of Phyllanthus extract on replication
index (Table 11 and 12, Fig. 4) showed an elevated level when
compared with the AFB1 treatment alone i.e., from 1.35 to
1.56, though still being lower than the normal level of 1.78.
The effect, after treatment with metabolic activation system,
shows the level from 1.23 to 1.54, i.e., again being much effec-
tive in comparison with that without metabolic activation
system.
Table 7 Analysis of chromosomal aberration after treatment with Aﬂatoxin B1 (AFB1) along with Phyllanthus amarus extract
in vitro, in the absence of S9 mix.
Treatments Durations
(h)
Metaphase
scored
Percent aberration
metaphase
Types of aberration (%) Aberration/
Cell ±SE
Including
gap
Excluding
gap
Chromatid Chromosome Total
AFB1 24 200 26.12 23.00 26.15 8.34 34.49 0.34 ± 0.03
48 200 44.00 40.17 47.47 21.00 68.47 0.68 ± 0.05
72 200 47.27 42.00 52.12 26.53 78.65 0.79 ± 0.08
AFB1 + PA1 24 200 22.22 19.51 21.00 7.87 28.87 0.29 ± 0.04
48 200 40.00 36.41 43.53 18.00 61.53 0.62 ± 0.06
72 200 43.18 38.21 48.18 21.50 69.68 0.70 ± 0.09
AFB1 + PA2 24 200 21.32 18.32 17.00 7.47 24.47 0.24 ± 0.03
48 200 38.73 34.00 41.13 16.13 57.26 0.57 ± 0.06
72 200 41.00 36.67 44.39 17.25 61.64 0.62 ± 0.08
AFB1 + PA3 24 200 20.00 16.00 16.00 5.00 21.00 0.21 ± 0.04
48 200 37.65 32.38 37.68 15.27 52.95 0.53 ± 0.05
72 200 39.00 34.77 40.98 15.75 56.73 0.57 ± 0.09
AFB1 + PA4 24 200 19.12 15.12 15.22 4.10 19.32 0.19 ± 0.03
48 200 37.00 31.89 35.00 13.00 48.00 0.48 ± 0.06
72 200 38.19 33.61 35.88 16.00 51.88 0.52 ± 0.06
Control
Normal 72 200 2.78 2.33 1.98 0.77 2.75 0.03 ± 0.01
DMSO+ PA2 72 200 3.88 1.56 2.58 1.00 3.58 0.04 ± 0.01
Note: PA; concentrations of Phyllanthus amarus extracts, AFB1 x/kg bw; Aﬂatoxin B1 5 lg/ml/culture, gap type of aberration is not included,
SE; standard error, DMSO; dimethyl sulphoxide. Calculations were signiﬁcant at <0.05 probability level.
Figure 2 Comparative in vitro anticlastogenic effect of Phyllanthus extract in absence of S9 mixture at 24 h, 48 h and 72 h of treatment
duration.
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Aqueous extract of P. amarus exhibited potent anticarcino-
genic activity against 20-methylcholanthrene induced sarcomaand increased the survival of tumor harboring mice. The
extract administration was also found to prolong the life span
of Dalton’s Lymphoma Ascites and Ehrlich Ascites
Carcinoma bearing mice and reduced the volume of
Table 8 Analysis of chromosomal aberration after treatment with Aﬂatoxin B1 (AFB1) along with Phyllanthus amarus extract
in vitro, in the presence of +S9 mix.
Treatments Durations
(h)
Metaphase
scored
Percent aberration
metaphase
Types of Aberration (%) Aberration/
Cell ± SE
Including
gap
Excluding
gap
Chromatid Chromosome Total
AFB1 24 200 27.28 23.84 27.55 8.98 36.53 0.37 ± 0.04
48 200 45.00 40.67 49.89 21.87 71.76 0.72 ± 0.08
72 200 50.55 43.25 54.50 28.35 82.85 0.83 ± 0.09
AFB1 + PA1 24 200 25.00 22.00 23.50 8.72 32.22 0.32 ± 0.04
48 200 40.00 36.50 45.00 20.00 65.00 0.65 ± 0.06
72 200 46.66 42.00 49.30 27.00 76.30 0.76 ± 0.09
AFB1 + PA2 24 200 24.00 20.88 20.00 7.30 27.30 0.27 ± 0.03
48 200 36.00 33.00 39.34 18.35 57.69 0.58 ± 0.06
72 200 43.99 39.00 46.32 23.45 69.77 0.70 ± 0.08
AFB1 + PA3 24 200 22.32 19.32 19.54 5.38 24.92 0.25 ± 0.04
48 200 36.12 32.22 34.25 18.10 52.35 0.52 ± 0.05
72 200 41.63 36.50 42.32 21.00 63.32 0.63 ± 0.09
AFB1 + PA4 24 200 21.00 19.00 17.00 4.77 21.77 0.22 ± 0.03
48 200 34.00 29.79 33.00 15.80 48.80 0.49 ± 0.06
72 200 37.65 32.00 36.00 17.60 53.60 0.54 ± 0.06
Control
Normal 72 200 2.70 2.00 1.98 0.90 2.88 0.03 ± 0.01
DMSO+ Phy2 72 200 3.55 1.50 2.88 1.00 3.88 0.04 ± 0.01
Note: PA; concentrations of Phyllanthus amarus extracts, AFB1 x/kg bw; Aﬂatoxin B1 5 lg/ml/culture, gap type of aberration is not included,
SE; standard error, DMSO; dimethyl sulphoxide. Calculations were signiﬁcant at <0.05 probability level.
Table 9 Analysis of sister chromatid exchanges (SCE) after treatment with Aﬂatoxin B1 along with Phyllanthus amarus extract
in vitro, in the absence of S9 mix.
Treatment Duration (h) Metaphase scored Total Range SCE/Cell ± SE
Aﬂatoxin B1 48 50 796 3–12 15.92 ± 1.50
AFB1 + PA1 48 50 702 3–12 14.04 ± 1.50
AFB1 + PA2 48 50 610 2–12 12.20 ± 1.50
AFB1 + PA3 48 50 526 1–11 10.52 ± 1.50
AFB1 + PA4 48 50 419 1–11 08.34 ± 1.50
Control
Normal 48 50 214 0–6 04.28 ± 1.00
DMSO 48 50 219 0–6 04.38 ± 1.00
DMSO+ PA3 48 50 215 0–6 04.30 ± 1.00
Note: PA; concentrations of Phyllanthus amarus extracts, AFB1 x/kg bw; Aﬂatoxin B1 5 lg/ml/culture, SE; standard error, DMSO; dimethyl
sulphoxide. Calculations were signiﬁcant at <0.05 probability level.
350 M.S. Ahmad et al.transplanted solid tumors. Antitumor and anticancer activity
of P. amarus may be evident by the inhibition of metabolic
activation of carcinogen as well as the inhibition of cell cycle
regulators [2]. In our experiments P. amarus extracts counter-
act the genotoxicity produced due to AFB1, a potent carcino-
gen signiﬁcantly in vitro and in vivo models.
It has been reported earlier that P. amarus prevents the
induction of tumor in rats by inhibition of N-methyl
N-nitrosoguanidine (MNNG) induced gastric carcinogenesis
[16]. Revathia et al, [17], observed increased lipid peroxidation
and decreased levels of antioxidant status in azaserine-induced
rat pancreatic carcinoma. Tumor cells generally display highlevels of lipid peroxidation, which in turn can stimulate cell
division and promote tumor growth primarily by setting up
an oxidant–antioxidant imbalance that favors neoplastic trans-
formation [18]. P. amarus administration to azaserine treated
rats restored lipid peroxidation levels to near control levels.
P. amarus exhibits anti-proliferative activity against various
types of cancer and thus suggesting that it may be able to reg-
ulate cell proliferation [19].
The chemoprotective effect of methanolic extract of the
P. amarus plant was studied against cyclophosphamide
(CTX) induced toxicity in mice. Administration of CTX
produced signiﬁcant myelo-suppression as seen from the
Table 10 Analysis of sister chromatid exchanges (SCE) after treatment with Aﬂatoxin B1 along with Phyllanthus amarus extract
in vitro, in the presence of S9 mix.
Treatment Duration (h) Metaphase scored Total Range SCE /Cell ± SE
Aﬂatoxin B1 48 50 888 3–12 17.76 ± 1.50
AFB1 + PA1 48 50 715 3–12 14.30 ± 1.50
AFB1 + PA2 48 50 652 2–12 13.04 ± 1.50
AFB1 + PA3 48 50 590 1–11 11.80 ± 1.50
AFB1 + PA4 48 50 488 1–11 09.76 ± 1.50
Control
Normal 48 50 213 0–6 04.26 ± 0.40
DMSO 48 50 217 0–6 04.34 ± 0.40
DMSO+ PA3 48 50 215 0–6 04.30 ± 0.40
Note: PA; concentrations of Phyllanthus amarus extracts, AFB1 x/kg bw; Aﬂatoxin B1 5 lg/ml/culture, SE; standard error, DMSO; dimethyl
sulphoxide. Calculations were signiﬁcant at <0.05 probability level.
Table 11 Analysis of cell cycle kinetics after treatment with Aﬂatoxin B1 along with Phyllanthus amarus extract in vitro, in the absence
of S9 mix.
Treatment Cell scored (%) cell in Replication index 2 · 3 chi square test
M1 M2 M3
Aﬂatoxin B1 200 68 29 03 1.35
AFB1 + PA1 200 66 31 03 1.37
AFB1 + PA2 200 61 35 04 1.43 Signiﬁcant
AFB1 + PA3 200 56 39 05 1.49 Signiﬁcant
AFB1 + PA4 200 51 42 07 1.56 Signiﬁcant
Normal 200 38 53 09 1.71
DMSO 200 34 54 12 1.78
DMSO+ PA3 200 35 52 13 1.78
Note: 2 · 3 Chi square (v2) test were conducted, AE; concentrations Phyllanthus amarus extracts, AFB1 x/kg bw; Aﬂatoxin B1 5 lg/ml/culture,
DMSO; dimethyl sulphoxide. Calculations were made at <0.05 probability level.
Table 12 Analysis of cell cycle kinetics after treatment with Aﬂatoxin B1 along with Phyllanthus amarus extract in vitro, in the
presence of S9 mix.
Treatment Cell scored (%) cell in Replication index 2 · 3 chi square test
M1 M2 M3
Aﬂatoxin B1 200 78 21 01 1.23
AFB1 + PA1 200 72 25 03 1.31
AFB1 + PA2 200 65 28 07 1.42 Signiﬁcant
AFB1 + PA3 200 59 32 09 1.50 Signiﬁcant
AFB1 + PA4 200 55 36 09 1.54 Signiﬁcant
Normal 200 37 53 10 1.73
DMSO 200 34 54 12 1.78
DMSO+ PA3 200 35 53 12 1.77
Note: 2 · 3 Chi square (v2) test were conducted, AE; concentrations Phyllanthus amarus extracts, AFB1 x/kg bw; Aﬂatoxin B1 5 lg/ml/culture,
DMSO; dimethyl sulphoxide. Calculations were made at <0.05 probability level.
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Administration of P. amarus extract at doses 250 and
750 mg/kg body weight signiﬁcantly reduced the myelo-
suppression and improved the WBC count, bone marrow cel-
lularity as well as the number of maturing monocytes that
accounted for its chemoprotective activity [20], All these works
were supporting our ﬁnding. Methanolic extract of P. amarus50, 200, and 1000 mg/kg body weight signiﬁcantly inhibited
gastric lesions, induced by intragastric administration of abso-
lute ethanol (8 ml/kg). Biochemical analysis indicated that
reduced glutathione (GSH) of gastric mucosa produced by
ethanol administration was signiﬁcantly elevated by treatment
with P. amarus extract. Aqueous and methanol extracts of
P. amarus produced an inhibition of rat paw edema up to
Figure 3 In vitro anticlastogenic effect of Phyllanthus extract in presence of S9 mixture at 24 h, 48 h and 72 h of treatment duration.
Figure 4 Antigenotoxic effect of Phyllanthus extract on sister chromatid exchanges in the absence as well as in the presence of metabolic
activation system.
352 M.S. Ahmad et al.42% compared to control in 3 h and continued up to 8 h.
Anti-oxidant activity of the extract as well as presence of
tannins in the extract may be responsible for these observed
activities [21].
The antimutagenic and anticarcinogenic potential of
P. amarus using the bacterial pre-incubation mutation assay
and an in vivo alkaline elution method for DNA single strandbreaks in hamster liver cells have been studied. The aqueous
extract of the entire plant showed an antimutagenic effect
against induction by 2-aminoﬂuorene (AF2), 2-aminoanthracene
(2AA) and 4-nitroquinolone-1-oxide (4 NQO) in Salmonella
typhimurium strains TA98 and TA100, and in Escherichia coli
WP2 uvrA/pKM101. All the results were dose-dependent.
Based on the alkaline elution method, the plant extract
Cancer ameliorating potential of Phyllanthus amarus 353prevented in vivo DNA single strand breaks caused by
dimethylnitrosamine (DMN) in hamster liver cells. These
results indicate that P. amarus possesses antimutagenic and
antigenotoxic property [22] and that were parallel to our work.
5. Conclusion
P. amarus extracts signiﬁcantly reduced the number of aberrant
cells and frequencies of aberration per cell at each concentration
and duration of exposure in vivo; similarly it reduced chromoso-
mal aberrations and sister chromatid exchanges and replication
index was enhanced in vitro that was statistically signiﬁcant at
<0.05 level. These results indicate that P. amarus possesses
antimutagenic and antigenotoxic property.
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